OncoBone Ventures attended the 5th Annual LSX Nordic Congress on September 6-7, 2022 in Copenhagen, Denmark. Tiina Kähkönen, Chief Scientific Officer of OncoBone Ventures gave a presentation titled: “Novel osteoimmuno-oncology (OIO) therapies for cancer bone metastasis” in the Spotlight session during the event.
You can find the recorded presentation in the following link: https://www.youtube.com/watch?v=6g1Rl2GVh1g
If you have any questions, please reach out to learn more at https://www.oncobonetherapeutics.com/contact-us/.